</Agent System Instructions>
<Blinded Review: TIME_ANON_0266>
**Composite Score:** 2.8 / 10.0 (Rigor: 0.7/3.5 | Claims: 0.7/2.5 | Biology: 0.6/2.0 | Reproducibility: 0.8/2.0)
**Bias Category:** Over-Interpretation/Clinical
**Verdict:** Reject (Fundamental Flaws)
**Study Modality:** Hybrid Computational + Wet-Lab
**Technology Maturity:** Commodity/Hype-Cycle Template
**Epistemic Stage:** Basic/Mechanistic Discovery

---

### 1. Executive Summary
This manuscript performs a secondary bioinformatic filtering and network-prediction exercise on previously generated RNA-seq/ncRNA-seq data (`[15, 16]`) from HepG2 cells transduced with recombinant adenovirus overexpressing Genotype 4 Swine Hepatitis E Virus ORF3 (`Ad_ORF3_1..3`, $n = 3$) versus GFP control (`Ad_GFP1..3`, $n = 3$). From 62 differentially expressed mRNAs, 319 lncRNAs, and 2,261 circRNAs, the authors manually select four biological themes ("regulating host cell innate immunity," "maintaining ERK activity," "inhibiting growth factor transport," and "inhibiting immune response") based on unadjusted $p < 0.05$ GO/KEGG annotations, subsetting 24 circRNAs and 4 lncRNAs to draw speculative circRNA–miRNA and cis-lncRNA–mRNA networks. No wet-lab validation (no qRT-PCR, no Western blot, no luciferase reporter, no viral infection assay) is performed, and the manuscript exhibits internal identifier mismatches between the Results sections, severe methodological omissions in the bioinformatics pipeline, and confusion between circRNAs and their linear host genes.

### 2. Methodological & Statistical Audit
- **Internal Identifier Contradictions for the 4 Selected lncRNAs:** Compare Section 3.2 (line 63) with Section 3.3 (line 74) and Discussion (line 83):
  - In Section 3.2 (line 63), the four screened lncRNAs are explicitly named **`MSTRG.10352`**, **`MSTRG.2063`**, **`MSTRG.23149`**, and **`MSTRG.7475`**.
  - Just 11 lines later in Section 3.3 (line 74) and Discussion (line 83), the four selected lncRNAs are instead listed as **`MSTRG.10342`** (`KCTD13`), **`MSTRG.2057`** (`AL139011`), **`MSTRG.23144`** (`AC138035`), and **`MSTRG.7478`** (`AL137002`)! Every single `MSTRG` identifier changes its numeric suffix between Section 3.2 and Section 3.3 (`10352` $\to$ `10342`, `2063` $\to$ `2057`, `23149` $\to$ `23144`, `7475` $\to$ `7478`), indicating either sloppy manual transcription or mixing of lncRNA assembly IDs with those of their neighboring cis-mRNA transcripts.
- **Conflation of circRNAs with Host Ensembl Gene IDs / Gene Symbols:** In Section 3.2 (lines 55–61), the authors list "circRNAs" using standard linear Ensembl gene IDs and HGNC gene symbols (e.g., `ENSG00000138279`, `ATP9B`, `VMP1`, `GNB1`, `GPC3`, `APLF`, `UBQLN1`) and state *"Among them, the expression of three genes was up-regulated, and five genes were down-regulated"*, without providing actual back-splice junction coordinates, circBase IDs, or distinguishing whether the circRNA or its parental linear mRNA was enriched in GO/KEGG. Moreover, in Discussion line 81, they state *"The hosting genes of the miRNAs targeted by the most significant differential circRNAs in each pathway were screened... namely GNB1, GPC3, ENSG00000138279, and APLF"*, confusing the parental host genes of the circRNAs with the "hosting genes of the miRNAs."
- **Complete Absence of Bioinformatic Pipeline Specification & Multiple Testing Control:** Section 2 (Materials and Methods) is only three short paragraphs (lines 28–40) and fails to name the sequencing platform, read depth, rRNA depletion / RNase R treatment, read aligner (e.g., STAR/HISAT2), circRNA caller (e.g., find_circ/CIRI2), differential expression software (e.g., DESeq2/edgeR), log2 fold-change cutoff, or miRNA target prediction software (e.g., TargetScan/miRanda). Differential expression and GO/KEGG screening rely on nominal $p < 0.05$ without false discovery rate (FDR) correction.

### 3. Biological / Experimental Grounding & Claim Proportionality
- **Claim: Genotype 4 Swine HEV ORF3 rewires circRNA-miRNA and lncRNA-mRNA networks in HepG2 cells to regulate innate immunity, maintain ERK activity, and inhibit growth factor transport** — `[Overstated]`. As the authors themselves admit at the end of the Discussion (line 85, *"these findings remain speculative"*), the study merely cherry-picks GO terms matching pre-existing literature keywords on ORF3 from an unvalidated $n = 3$ adenovirus-ORF3 overexpression RNA-seq dataset and draws unvalidated in silico correlation/proximity graphs.
- **Claim: `KCTD13 (MSTRG.10342)` regulates `TAOK2` and `INO80E`, and `AC138035` regulates `TRIM41`, `RACK1`, and `TRIM52`** — `[Fragile]`. Defining cis-regulation purely by genomic proximity within $\pm 100\text{ kbp}$ on a chromosome (line 40) without any knockdown, overexpression, or chromatin-interaction data provides no evidence of causal regulation.

### 4. Reproducibility & Data Completeness
- **Missing Raw Data & Accessions:** No NCBI SRA, GEO, or CNCB GSA accession numbers are provided for the six sequencing libraries (`Ad_GFP1..3`, `Ad_ORF3_1..3`), and Tables 1 and 2 are omitted from the extracted text.
- **Missing Methodological Parameters:** Viral MOI, transduction duration, RNA extraction kit, library prep kit, and all bioinformatic software versions/parameters are omitted, referring only to previous Chinese-language or companion citations `[15, 16]`.
</Blinded Review: TIME_ANON_0266>
